Consequently, AD treatment induced the interaction of phosphorylated PLCγ1 with TrkB receptors and the phosphorylation of CREB, but not that of Akt [9], which is consistent of them being downstream mediators of the PLCγ1 and Shc pathways, respectively. The gene discussed is CREB1; the disease is Alzheimer disease.